Can we well assess the relative efficacy and tolerability of a new drug versus others at the time of marketing authorization using mixed treatment comparisons? A detailed illustration with escitalopram
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Christophe Lançon Pierre-Michel Llorca Mondher Toumi Mélanie Brignone |
| Publication date | September 24, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |